Faculty profile

Paula de Robles

Back to faculty

Clinical Associate ProfessorDCNSUniversity of Calgary

Paula de Robles

Clinical Associate Professor

DCNS

University of Calgary

Calgary, Alberta, Canada

Supervision signals

Clinical faculty often co-supervise; many graduate programs need a core faculty member as the main supervisor.
5 publications in the last five years, latest in 2026.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

514

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Calgary profile.

Latest papers

Niacin Modulates Immune Responses in a Phase I Dose-Escalation Clinical Trial of Newly Diagnosed Glioblastoma
Neurology Neuroimmunology & Neuroinflammation · 2026
A phase I-II study of niacin in patients with newly diagnosed glioblastoma: safety and interim phase II analysis.
Journal of neuro-oncology · 2025
Canadian Consensus Guidelines for the Diagnosis and Treatment of Autoimmune Encephalitis in Adults.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques · 2024

All 10 publications

Latest funding

Harnessing neuroinflammation to develop new treatments for multiple sclerosis and glioblastoma
CIHR · 2018 · Co-investigator
$5,784,461
Mobilizing anti-tumor microglia/macrophages with niacin to improve the prognosis of glioblastoma: Bench to clinical trial and back.
CIHR · 2017 · Co-investigator
$1,243,125
Mobilizing anti-tumor microglia/macrophages to improve the prognosis of glioblastoma: Bench to clinical trial and back
CIHR · 2016 · Co-investigator
$100,000

All 3 grants and awards

10 publications.

Niacin Modulates Immune Responses in a Phase I Dose-Escalation Clinical Trial of Newly Diagnosed Glioblastoma

Candice C. Poon, Kathleen Margaret Hagen, Susobhan Sarkar, Reza Mirzaei, Claudia Silva, Aito Ueno, Paula A. de Robles, Gloria Roldan-Urgoiti, V. Wee Yong

Neurology Neuroimmunology & Neuroinflammation2026Open Access

DOI: 10.1212/nxi.0000000000200530 PMID: 41632924

A phase I-II study of niacin in patients with newly diagnosed glioblastoma: safety and interim phase II analysis.

Roldan Urgoiti G, de Robles P, Tsang RY, Willson M, Ghosh S, Faruqi M, Lim G, Loewen S, Nordal R, Cairncross G, Leckie C, Poon CC, Yong VW

Journal of neuro-oncology2025

DOI: 10.1007/s11060-025-05351-z PMID: 41313494

Canadian Consensus Guidelines for the Diagnosis and Treatment of Autoimmune Encephalitis in Adults.

Hahn C, Budhram A, Alikhani K, AlOhaly N, Beecher G, Blevins G, Brooks J, Carruthers R, Comtois J, Cowan J, de Robles P, Hébert J, Kapadia RK, Lapointe S, Mackie A, Mason W, McLane B, Muccilli A, Poliakov I, Smyth P, Williams KG, Uy C, McCombe JA

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques202428 citationsOpen Access

DOI: 10.1017/cjn.2024.16 PMID: 38312020

Long-Term Follow-Up of Non-Paraneoplastic Autoimmune Encephalitis: A Canadian Single-Center Experience.

Hansen M, Kapadia R, Alikhani K, de Robles P, Hahn C

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques2024

DOI: 10.1017/cjn.2024.278 PMID: 39297442

A real-world observation of patients with glioblastoma treated with a personalized peptide vaccine.

Latzer P, Zelba H, Battke F, Reinhardt A, Shao B, Bartsch O, Rabsteyn A, Harter J, Schulze M, Okech T, Golf A, Kyzirakos-Feger C, Kayser S, Pieper N, Feldhahn M, Wünsche J, Seitz C, Hadaschik D, Garbe C, Hauser TK, la Fougère C, Biskup D, Brooke D, Parker D, Martens UM, Illerhaus G, Blumenthal DT, Merrell R, Lorenzo LS, Hidvégi M, de Robles P, Kebir S, Li WW, Li VW, Williams M, Miller AM, Kesari S, Castro M, Desjardins A, Ashley DM, Friedman HS, Wen PY, Neil EC, Iwamoto FM, Sipos B, Geletneky K, Zender L, Glas M, Reardon DA, Biskup S

Nature communications2024

DOI: 10.1038/s41467-024-51315-8 PMID: 39127809

Systematic review of the clinical spectrum of CASPR2 antibody syndrome.

Boyko M, Au KLK, Casault C, de Robles P, Pfeffer G

Journal of neurology202096 citations

DOI: 10.1007/s00415-019-09686-2 PMID: 31912210

The worldwide incidence and prevalence of primary brain tumors: a systematic review and meta-analysis.

de Robles P, Fiest KM, Frolkis AD, Pringsheim T, Atta C, St Germaine-Smith C, Day L, Lam D, Jette N

Neuro-oncology2015357 citationsFirst authorOpen Access

DOI: 10.1093/neuonc/nou283 PMID: 25313193

An analysis of image texture, tumor location, and MGMT promoter methylation in glioblastoma using magnetic resonance imaging.

Drabycz S, Roldán G, de Robles P, Adler D, McIntyre JB, Magliocco AM, Cairncross JG, Mitchell JR

NeuroImage2010

DOI: 10.1016/j.neuroimage.2009.09.049 PMID: 19796694

Predicting MGMT methylation status of glioblastomas from MRI texture.

Levner I, Drabycz S, Roldan G, De Robles P, Cairncross JG, Mitchell R

Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention2009

DOI: 10.1007/978-3-642-04271-3_64 PMID: 20426152

Methylation status of MGMT gene promoter in meningiomas.

de Robles P, McIntyre J, Kalra S, Roldán G, Cairncross G, Forsyth P, Magliocco T, Hamilton M, Easaw J

Cancer genetics and cytogenetics200833 citationsFirst author

DOI: 10.1016/j.cancergencyto.2008.07.006 PMID: 18992637

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Paula de Robles

Research

Latest papers

Latest funding

Niacin Modulates Immune Responses in a Phase I Dose-Escalation Clinical Trial of Newly Diagnosed Glioblastoma

A phase I-II study of niacin in patients with newly diagnosed glioblastoma: safety and interim phase II analysis.

Canadian Consensus Guidelines for the Diagnosis and Treatment of Autoimmune Encephalitis in Adults.

Long-Term Follow-Up of Non-Paraneoplastic Autoimmune Encephalitis: A Canadian Single-Center Experience.

A real-world observation of patients with glioblastoma treated with a personalized peptide vaccine.

Systematic review of the clinical spectrum of CASPR2 antibody syndrome.

The worldwide incidence and prevalence of primary brain tumors: a systematic review and meta-analysis.

An analysis of image texture, tumor location, and MGMT promoter methylation in glioblastoma using magnetic resonance imaging.

Predicting MGMT methylation status of glioblastomas from MRI texture.

Methylation status of MGMT gene promoter in meningiomas.

Harnessing neuroinflammation to develop new treatments for multiple sclerosis and glioblastoma

Mobilizing anti-tumor microglia/macrophages with niacin to improve the prognosis of glioblastoma: Bench to clinical trial and back.

Mobilizing anti-tumor microglia/macrophages to improve the prognosis of glioblastoma: Bench to clinical trial and back

Frequent collaborators

Katayoun Alikhani

Gregory Cairncross

Candice Poon

Voon Yong

Mark Hamilton

Ronak Kapadia

Warren Mason

Alexandra Muccilli

Adrian Budhram

Nasser AlOhaly

Kirsten Fiest

Gerald Pfeffer

Juthaporn Cowan

Grayson Beecher

Gregg Blevins

Reza Mirzaei

Tamara Pringsheim

Sunita Ghosh

Penelope Smyth

Nathalie Jette